| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.92B | 101.01B | 92.33B | 94.51B | 76.09B | 62.85B |
| Gross Profit | 22.40B | 21.26B | 17.92B | 19.21B | 17.98B | 14.96B |
| EBITDA | 6.10B | 5.63B | 3.06B | 5.22B | 5.44B | 4.93B |
| Net Income | 791.00M | 763.00M | -1.16B | 885.73M | 1.75B | 1.09B |
Balance Sheet | ||||||
| Total Assets | 101.00B | 100.04B | 98.58B | 92.44B | 78.91B | 69.39B |
| Cash, Cash Equivalents and Short-Term Investments | 4.93B | 4.75B | 6.85B | 6.30B | 6.63B | 3.48B |
| Total Debt | 42.03B | 42.56B | 39.37B | 33.67B | 21.50B | 17.68B |
| Total Liabilities | 64.06B | 62.03B | 57.70B | 51.62B | 38.80B | 31.95B |
| Stockholders Equity | 36.27B | 37.33B | 37.22B | 37.10B | 36.74B | 34.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 684.00M | -3.08B | -4.80B | -22.99M | 712.74M |
| Operating Cash Flow | 0.00 | 6.14B | 353.00M | -466.24M | 2.83B | 3.01B |
| Investing Cash Flow | 0.00 | -4.98B | -3.20B | -6.65B | -3.44B | -1.86B |
| Financing Cash Flow | 0.00 | -3.67B | 2.90B | 7.66B | 2.11B | -1.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥18.63B | 14.51 | ― | 3.63% | 18.02% | 18.04% | |
66 Neutral | ¥24.12B | 10.69 | ― | 3.87% | -3.41% | -12.83% | |
66 Neutral | ¥17.71B | 9.37 | ― | 3.24% | 13.09% | 89.45% | |
66 Neutral | ¥15.40B | 12.53 | ― | 2.77% | 1.30% | -5.03% | |
66 Neutral | ¥22.37B | 22.03 | ― | 4.77% | 7.19% | ― | |
64 Neutral | ¥22.85B | 13.39 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Harima Chemicals Group, Inc. announced changes in its senior personnel, effective January 1, 2026, following a Board of Directors’ meeting. These changes include new appointments for key positions within the company, which may influence its strategic direction and operational efficiency, particularly in its paper chemicals division.
Harima Chemicals Group, Inc. reported a discrepancy between its forecasted and actual consolidated results for the second quarter of fiscal 2025. Despite lower net sales due to decreased sales in several business segments, the company achieved higher operating and net income than anticipated, primarily due to reduced raw material costs and equity-method gains.
Harima Chemicals Group, Inc. reported its consolidated financial results for the second quarter ending September 30, 2025, showing a 4.3% increase in net sales compared to the previous year. Despite a significant drop in comprehensive income, the company achieved notable growth in operating and ordinary income, reflecting a strong operational performance.